diphenhydramine hydrochloride omega pharma 50 mg comp.
omega pharma belgium sa-nv - chlorhydrate de diphénhydramine 50 mg - eq. diphénhydramine 43,8 mg - comprimé - 50 mg - chlorhydrate de diphénhydramine 50 mg - diphenhydramine
ibuprofen/pseudoephedrine hydrochloride sanofi 200 mg - 30 mg compr. pellic.
opella healthcare belgium sa-nv - ibuprofène 200 mg; chlorhydrate de pseudoéphédrine 30 mg - comprimé pelliculé - 200 mg - 30 mg - chlorhydrate de pseudoéphédrine 30 mg; ibuprofène 200 mg - pseudoephedrine, combinations; r05x other cold preparations
tamsulosin hydrochloride synthon 0.4 mg gél. lib. modif.
synthon b.v. - chlorhydrate de tamsulosine 0,4 mg - gélule à libération modifiée - 0,4 mg - chlorhydrate de tamsulosine 0.4 mg - tamsulosin
levamisole hydrochloride 80 % kela
kela sa-nv - chlorhydrate de lévamisole 800 mg/g - poudre orale - chlorhydrate de lévamisole 800 mg/g - levamisole - porc
sevelamer hydrochloride waymade 400 mg compr. pellic.
waymade b.v. - chlorhydrate de sevelamer 400 mg - comprimé pelliculé - 400 mg - chlorhydrate de sevelamer 400 mg - sevelamer
sevelamer hydrochloride waymade 800 mg compr. pellic.
waymade b.v. - chlorhydrate de sevelamer 800 mg - comprimé pelliculé - 800 mg - chlorhydrate de sevelamer 800 mg - sevelamer
epirubicin hydrochloride (lyophilised), 50 mg, suspension injectable, b/1 vial
serum institute of india pvt ltd - l'Épirubicine - suspension injectable - 50 mg
infinito®
bayer ag - propamocarbe hydrochloride; fluopicolide - suspension concentrée (sc) - 55.6 %625 g/l; 5.56 %62.5 g/l; - 625 g/l hydrochlorure de propamocarbe; 62,5 g/l fluopicolide - fongicide ;
bupivacaine hydrochloride, 5mg/ml, ampoule injectable, 10x4ml
ihdlife inc, - bupivacaine hydrochloride bp - ampoule injectable - 5mg/ml
clopidogrel tad
tad pharma gmbh - clopidogrel (as hydrochloride) - peripheral vascular diseases; stroke; myocardial infarction - agents antithrombotiques - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.